Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults

Abstract Background Type-2 diabetes (T2D), chronic kidney disease, and heart failure (HF) share epidemiological and pathophysiological features. Although their prevalence was described, there is limited contemporary, high-resolution, epidemiological data regarding the overlap among them. We aimed to...

Full description

Bibliographic Details
Main Authors: Meir Schechter, Cheli Melzer Cohen, Ilan Yanuv, Aliza Rozenberg, Gabriel Chodick, Johan Bodegård, Lawrence A. Leiter, Subodh Verma, Hiddo J. Lambers Heerspink, Avraham Karasik, Ofri Mosenzon
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:https://doi.org/10.1186/s12933-022-01521-9
_version_ 1818211678926405632
author Meir Schechter
Cheli Melzer Cohen
Ilan Yanuv
Aliza Rozenberg
Gabriel Chodick
Johan Bodegård
Lawrence A. Leiter
Subodh Verma
Hiddo J. Lambers Heerspink
Avraham Karasik
Ofri Mosenzon
author_facet Meir Schechter
Cheli Melzer Cohen
Ilan Yanuv
Aliza Rozenberg
Gabriel Chodick
Johan Bodegård
Lawrence A. Leiter
Subodh Verma
Hiddo J. Lambers Heerspink
Avraham Karasik
Ofri Mosenzon
author_sort Meir Schechter
collection DOAJ
description Abstract Background Type-2 diabetes (T2D), chronic kidney disease, and heart failure (HF) share epidemiological and pathophysiological features. Although their prevalence was described, there is limited contemporary, high-resolution, epidemiological data regarding the overlap among them. We aimed to describe the epidemiological intersections between T2D, HF, and kidney dysfunction in an entire database, overall and by age and sex. Methods This is a cross-sectional analysis of adults ≥ 25 years, registered in 2019 at Maccabi Healthcare Services, a large healthcare maintenance organization in Israel. Collected data included sex, age, presence of T2D or HF, and last estimated glomerular filtration rate (eGFR) in the past two years. Subjects with T2D, HF, or eGFR < 60 mL/min/1.73 m2 were defined as within the diabetes-cardio-renal (DCR) spectrum. Results Overall, 1,389,604 subjects (52.2% females) were included; 445,477 (32.1%) were 25– < 40 years, 468,273 (33.7%) were 40– < 55 years, and 475,854 (34.2%) were ≥ 55 years old. eGFR measurements were available in 74.7% of the participants and in over 97% of those with T2D or HF. eGFR availability increased in older age groups. There were 140,636 (10.1%) patients with T2D, 54,187 (3.9%) with eGFR < 60 mL/min/1.73m2, and 11,605 (0.84%) with HF. Overall, 12.6% had at least one condition within the DCR spectrum, 2.0% had at least two, and 0.23% had all three. Cardiorenal syndrome (both HF and eGFR < 60 mL/min/1.73m2) was prevalent in 0.40% of the entire population and in 2.3% of those with T2D. In patients with both HF and T2D, 55.2% had eGFR < 60 mL/min/1.73m2 and 15.8% had eGFR < 30 mL/min/1.73m2. Amongst those within the DCR spectrum, T2D was prominent in younger participants, but was gradually replaced by HF and eGFR < 60 mL/min/1.73m2 with increasing age. The congruence between all three conditions increased with age. Conclusions This large, broad-based study provides a contemporary, high-resolution prevalence of the DCR spectrum and its components. The results highlight differences in dominance and degree of congruence between T2D, HF, and kidney dysfunction across ages.
first_indexed 2024-12-12T05:36:19Z
format Article
id doaj.art-f4e41b35e48048809e9286d06c138961
institution Directory Open Access Journal
issn 1475-2840
language English
last_indexed 2024-12-12T05:36:19Z
publishDate 2022-06-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj.art-f4e41b35e48048809e9286d06c1389612022-12-22T00:36:07ZengBMCCardiovascular Diabetology1475-28402022-06-012111910.1186/s12933-022-01521-9Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adultsMeir Schechter0Cheli Melzer Cohen1Ilan Yanuv2Aliza Rozenberg3Gabriel Chodick4Johan Bodegård5Lawrence A. Leiter6Subodh Verma7Hiddo J. Lambers Heerspink8Avraham Karasik9Ofri Mosenzon10Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical CenterMaccabi Institute for Research and Innovation, Maccabi Healthcare ServicesDiabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical CenterDiabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical CenterMaccabi Institute for Research and Innovation, Maccabi Healthcare ServicesCardiovascular, Renal and Metabolism, Medical Department, BioPharmaceuticals, AstraZenecaLi Ka Shing Knowledge Institute, St. Michael’s Hospital, University of TorontoDivision of Cardiac Surgery, St. Michael’s Hospital, University of TorontoDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of GroningenMaccabi Institute for Research and Innovation, Maccabi Healthcare ServicesDiabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical CenterAbstract Background Type-2 diabetes (T2D), chronic kidney disease, and heart failure (HF) share epidemiological and pathophysiological features. Although their prevalence was described, there is limited contemporary, high-resolution, epidemiological data regarding the overlap among them. We aimed to describe the epidemiological intersections between T2D, HF, and kidney dysfunction in an entire database, overall and by age and sex. Methods This is a cross-sectional analysis of adults ≥ 25 years, registered in 2019 at Maccabi Healthcare Services, a large healthcare maintenance organization in Israel. Collected data included sex, age, presence of T2D or HF, and last estimated glomerular filtration rate (eGFR) in the past two years. Subjects with T2D, HF, or eGFR < 60 mL/min/1.73 m2 were defined as within the diabetes-cardio-renal (DCR) spectrum. Results Overall, 1,389,604 subjects (52.2% females) were included; 445,477 (32.1%) were 25– < 40 years, 468,273 (33.7%) were 40– < 55 years, and 475,854 (34.2%) were ≥ 55 years old. eGFR measurements were available in 74.7% of the participants and in over 97% of those with T2D or HF. eGFR availability increased in older age groups. There were 140,636 (10.1%) patients with T2D, 54,187 (3.9%) with eGFR < 60 mL/min/1.73m2, and 11,605 (0.84%) with HF. Overall, 12.6% had at least one condition within the DCR spectrum, 2.0% had at least two, and 0.23% had all three. Cardiorenal syndrome (both HF and eGFR < 60 mL/min/1.73m2) was prevalent in 0.40% of the entire population and in 2.3% of those with T2D. In patients with both HF and T2D, 55.2% had eGFR < 60 mL/min/1.73m2 and 15.8% had eGFR < 30 mL/min/1.73m2. Amongst those within the DCR spectrum, T2D was prominent in younger participants, but was gradually replaced by HF and eGFR < 60 mL/min/1.73m2 with increasing age. The congruence between all three conditions increased with age. Conclusions This large, broad-based study provides a contemporary, high-resolution prevalence of the DCR spectrum and its components. The results highlight differences in dominance and degree of congruence between T2D, HF, and kidney dysfunction across ages.https://doi.org/10.1186/s12933-022-01521-9Type-2 DiabetesHeart FailureChronic Kidney DiseaseCross-sectional StudyEpidemiologyDiabetes-cardio-renal Spectrum
spellingShingle Meir Schechter
Cheli Melzer Cohen
Ilan Yanuv
Aliza Rozenberg
Gabriel Chodick
Johan Bodegård
Lawrence A. Leiter
Subodh Verma
Hiddo J. Lambers Heerspink
Avraham Karasik
Ofri Mosenzon
Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults
Cardiovascular Diabetology
Type-2 Diabetes
Heart Failure
Chronic Kidney Disease
Cross-sectional Study
Epidemiology
Diabetes-cardio-renal Spectrum
title Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults
title_full Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults
title_fullStr Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults
title_full_unstemmed Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults
title_short Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults
title_sort epidemiology of the diabetes cardio renal spectrum a cross sectional report of 1 4 million adults
topic Type-2 Diabetes
Heart Failure
Chronic Kidney Disease
Cross-sectional Study
Epidemiology
Diabetes-cardio-renal Spectrum
url https://doi.org/10.1186/s12933-022-01521-9
work_keys_str_mv AT meirschechter epidemiologyofthediabetescardiorenalspectrumacrosssectionalreportof14millionadults
AT chelimelzercohen epidemiologyofthediabetescardiorenalspectrumacrosssectionalreportof14millionadults
AT ilanyanuv epidemiologyofthediabetescardiorenalspectrumacrosssectionalreportof14millionadults
AT alizarozenberg epidemiologyofthediabetescardiorenalspectrumacrosssectionalreportof14millionadults
AT gabrielchodick epidemiologyofthediabetescardiorenalspectrumacrosssectionalreportof14millionadults
AT johanbodegard epidemiologyofthediabetescardiorenalspectrumacrosssectionalreportof14millionadults
AT lawrencealeiter epidemiologyofthediabetescardiorenalspectrumacrosssectionalreportof14millionadults
AT subodhverma epidemiologyofthediabetescardiorenalspectrumacrosssectionalreportof14millionadults
AT hiddojlambersheerspink epidemiologyofthediabetescardiorenalspectrumacrosssectionalreportof14millionadults
AT avrahamkarasik epidemiologyofthediabetescardiorenalspectrumacrosssectionalreportof14millionadults
AT ofrimosenzon epidemiologyofthediabetescardiorenalspectrumacrosssectionalreportof14millionadults